• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, SA VITEK MASS SPECTROMETER; VITEK® MS¿

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, SA VITEK MASS SPECTROMETER; VITEK® MS¿ Back to Search Results
Model Number 410895
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Event Description
A customer in (b)(6) contacted biomérieux to report the occurrence of a misidentification of group a strep as streptococcus dysgalactiae in association with the vitek® ms system.The customer stated that in addition to the streptococcus strain,the inoculated media displayed growth of staphylococcus aureus, acinetobacter baumannii and enterobacter cloacae.They isolated the strep on a blood plate and observed hemolysis.Vitek ms provided a result of streptococcus dysgalactiae ssp equisimilis/ streptococcus dysgalactiae ssp dysgalactiae.Alternative method testing (pathdx2, oxoid and novamed strep a stick) provided results of "positive" for group a strep.Bruker ms gave streptococcus dysgalactiae but with a remark to check also for streptococcus pyogenes.The customer stated that the vitek ms result was not reported to the physician; therefore had no effect on patient treatment decisions.There was a delay of undisclosed duration in reporting the correct result.The customer also indicated there was no adverse impact to the patient's state of health.Biomérieux requested strain submittal from the customer.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
A customer in israel contacted biomérieux to report the occurrence of a misidentification of group a strep as streptococcus dysgalactiae in association with the vitek® ms system.An internal biomérieux investigation was performed.The customer strain was not submitted for evaluation.All data provided from the tests performed were analyzed.Conclusion on the system: => system was operational during the tests.=> the customer's spot preparation quality was non-optimal.The "all peaks number" from the calibrator strain is quite heterogeneous - it can be extrapolated to sample spot preparation.Conclusion on the identification: based on the complaint description, the most probable identification is group a streptococcus.To confirm the identification to the species name, molecular method has to be performed (it is considered as the reference method).Vitek ms gave low discrimination to s.Dysgalactiae ssp dysgalactiae - s.Dysgalactiae ssp equisimilis for this strain.Streptococcus dysgalactiae ssp equisimilis are (mostly) beta-haemolytic and can harbor carbohydrate antigens of lancefield group a, c, g or l.So vitek ms results are not inconsistent with complementary tests.Furthermore, vitek 2 and bruker testing gave the same result as the vitek ms.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK MASS SPECTROMETER
Type of Device
VITEK® MS¿
Manufacturer (Section D)
BIOMERIEUX, SA
3 route de port michaud
la balme les grottes isere, 38390
FR  38390
MDR Report Key7818868
MDR Text Key119034109
Report Number3002769706-2018-00169
Device Sequence Number1
Product Code PEX
UDI-Device Identifier03573026359119
UDI-Public03573026359119
Combination Product (y/n)N
PMA/PMN Number
DEN130013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 09/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number410895
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/02/2018
Initial Date FDA Received08/27/2018
Supplement Dates Manufacturer Received08/30/2018
Supplement Dates FDA Received09/26/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-